Humana Q2 GAAP EPS falls to $4.51; raises adjusted 2025 EPS and revenue outlook
Humana reported second-quarter 2025 GAAP EPS of $4.51, down from $5.62 a year earlier, and adjusted EPS of $6.27, down from $6.96. Revenue rose to $32.4 billion from $29.5 billion. The company cut its full-year 2025 GAAP EPS guidance to about $13.77 from about $14.68 while raising adjusted EPS guidance to about $17.00 from $16.25 and revenue guidance to at least $128 billion, so headline measures moved in different directions.
Key points
- 2Q25 GAAP EPS was $4.51 versus $5.62 in 2Q24; adjusted EPS was $6.27 versus $6.96.
- 2Q25 Insurance segment benefit ratio was 89.9 percent, in line with the previously disclosed expectation of approximately 90 percent.
- FY 2025 individual Medicare Advantage membership decline is now expected to be up to 500,000, down from approximately 550,000 previously.
- CenterWell Primary Care now expects FY 2025 net patient growth of 50,000 to 70,000, up from 30,000 to 50,000.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.